No Data
No Data
Express News | Phasebio Pharmaceuticals: Under Plan, Intends to Liquidate Its Remaining Assets & Subsequently Wind-Down Operations
Express News | Phasebio Pharmaceuticals: Bankruptcy Court Entered Order Approving 1St Amended Combined Disclosure Statement & Chapter 11 Plan on Final Basis
Bankrupt PhaseBio Pharma Finds Buyers for Secondary Assets After Auction -- Market Talk
SFJ Pharmaceuticals Announces Closing of Transfer of Bentracimab Assets From PhaseBio Pharmaceuticals
Delisting of Securities of PhaseBio Pharmaceuticals, Inc.; Zovio Inc.; Fast Radius, Inc.; and Kismet Acquisition Three Corp. From The Nasdaq Stock Market
PhaseBio Pharmaceuticals (NASDAQ:PHAS) Trading Up 7%
71086900 : You can’t buy it
Praneeth tharindu : Can buy?